Cetuximab added to neoadjuvant chemotherapy enables life-saving surgery in patients with liver lesions linked to colorectal cancer, according to a report in The Lancet Oncology.
It says that while removal of colorectal liver metastases is a potential cure, the disease has traditionally been inoperable in up to 80% of patients.
But research now shows that neoadjuvant treatment with irinotecan or oxaliplatin-based...
National Cancer Institute
NCI Cancer Bulletin
September 22, 2009 • Volume 6 / Number 18
Many herbs, dietary supplements, and even vitamins are suspected of interfering with chemotherapy and radiation therapy, and doctors now routinely advise patients who are undergoing cancer treatment to avoid taking these products.
At the same time, cancer researchers have been intrigued by the potent and beneficial biological activity shown by some natural products...
New research details drug therapies in 2009 in Therapeutic Advances in Medical Oncology, published by SAGE
Los Angeles, London, New Delhi, Singapore and Washington DC (August 21, 2009) – Colorectal cancer (CRC) is the second leading cause of cancer-related death in the Western world. Fortunately physicians today have an abundance of drug therapies available to improve survival...
ScienceDaily (July 28, 2009) — For the 29,000 patients in the United States with metastatic colorectal cancer, chemotherapy with irinotecan is a standard treatment that has been shown to improve survival. But for more than one in 10 of these patients, a variation in their DNA means that this treatment could result in a severe reduction in their white blood cell count, leading to a high risk of bacterial infection and possible subsequent death.
03.31.09, 08:00 PM EDT
Finding, called 'not overwhelming,' applies only to those with particular gene mutation
WEDNESDAY, April 1 (HealthDay News) -- People with advanced colorectal cancer were modestly helped by the drug Erbitux, as long as they didn't have a particular gene mutation, a new study reports.
The study involved more than 1,100 people who had metastatic colorectal cancer that could not be surgically removed. Half were given a standard chemotherapy regimen...
